Sensex, Nifty trade sharply higher despite geopolitical jitters
Indian equity benchmarks traded sharply higher on Friday, mirroring gains in global markets despite fresh geopolitical tensions and concerns over the closure of the Strait of Hormuz.
Indian equity benchmarks traded sharply higher on Friday, mirroring gains in global markets despite fresh geopolitical tensions and concerns over the closure of the Strait of Hormuz.
The company’s board has declared an interim dividend of Rs 11 per equity share of Rs 1 each for FY26.
The conclave aims to position Uttar Pradesh as a leading pharmaceutical and medical device manufacturing hub, supported by robust infrastructure, a vast consumer market, and forward-looking, investor-friendly policies.
According to an official statement, the company’s total revenue from operations in Q2FY26 increased by almost 9% to Rs 14,478.31 crore from Rs 13,291.39 crore, on an year-on-year (YoY) basis.
"While the litigation between Incyte Corporation and the company continues, the preliminary injunction is no longer in effect," the statement by Sun Pharma said.
Mumbai-based Sun Pharma, including its subsidiaries, and Sun Pharma Advanced Research Company (SPARC) on Wednesday announced the signing of a licensing agreement for commercialisation of benzyl alcohol and propylene glycol-free phenobarbital sodium powder for injection in the US.
Sun Pharma now has the exclusive right to commercialise Winlevi in the US and Canada. Cassiopea will be the exclusive supplier of the product
Bourses in Shanghai, Tokyo and Seoul ended on a positive note, while Hong Kong was in the red.
This is in addition to the donations being offered by Lilly to the Indian government that will potentially help alleviate the burden of COVID-19, Visini said.
Gainers on the Sensex were led by Sun Pharma, rising 2.49 per cent, followed by ONGC, Bharti Airtel, IndusInd Bank, HUL, ITC, NTPC AND ICICI Bank.
